Profile of EDWARDS LIFESCIENCES CORP(NYSE:EW) stock

EDWARDS LIFESCIENCES CORP80.04

NYSE:EW (2/7/2023, 7:04:00 PM)+0.95 (+1.2%)

After market: 80.05 +0.01 (+0.01%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS Sector	Health Care
GICS Industry	Health Care Equipment & Supplies

Chartmill FA Rating

Valuation		Growth
Profitability		Health
Dividend

Overview

Earnings (Last)	01-31 2023-01-31/amc	Earnings (Next)	04-24 2023-04-24/amc
Ins Owners	0.16%	Inst Owners	80.44%
Market Cap	49.49B	Shares	618.26M
PE	32.8	Fwd PE	30.89
Dividend Yield	N/A	Analysts	75.29
IPO	03-27 2000-03-27

Stock Screener Links

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 15,700 full-time employees. The company went IPO on 2000-03-27. The firm is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. The company also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease.

Company Info

EDWARDS LIFESCIENCES CORP

One Edwards Way

Irvine CALIFORNIA 92614

P: 19492502500.0

CEO: Michael A. Mussallem

Employees: 15700

Website: https://www.edwards.com

EW News

2 days ago - ChartmillWhich S&P500 stocks are moving on Monday?

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session.

2 days ago - ChartmillThese S&P500 stocks are gapping in today's session

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

6 days ago - Market News VideoInteresting EW Put And Call Options For March 24th

7 days ago - The Motley Fool2 Top Dividend Growth Stocks to Buy in February

They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace.

7 days ago - Market News VideoJohnson Controls International Takes Over #160 Spot From Edwards Lifesciences

7 days ago - Seeking AlphaEdwards Lifesciences Non-GAAP EPS of $0.64 beats by $0.03, revenue of $1.35B beats by $20M (NYSE:EW)

Edwards Lifesciences press release (EW): Q4 Non-GAAP EPS of $0.64 beats by $0.03.Revenue of $1.35B (+1.5% Y/Y) beats by $20M.Shares +2.3%.Q4 TAVR sales were flat; constant...

EDWARDS LIFESCIENCES CORP (EW) 80.04 +0.95 (+1.2%)

80.04 +0.95 (+1.2%)